News | March 09, 2022
SII’s Covovax approved for 12-17 years age group
The DCGI has already approved Covovax for restricted use in emergency situations in adults on December 28th 2021
The DCGI has already approved Covovax for restricted use in emergency situations in adults on December 28th 2021
Raising awareness about glaucoma is crucial in India where it is the leading cause of irreversible blindness with at least 12 million people affected and almost 1.2 million people blind from the disease
As the Covid-19 pandemic continues to have a disproportionate impact on women, Organon issues a call to action for other leaders to create opportunities to focus on women’s health
Sense anticipates launching Veros Covid-19 in Europe this quarter, initially in Ireland, Benelux and the Nordic regions
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
Dr. Muffazal Lakdawala performs the largest series of complete robotic gastric bypass surgery in India
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
Expands AbbVie's neuroscience portfolio, adding first-in-class modulators of the synaptic vesicle protein 2A, including lead molecule SDI-118 currently in Phase 1b studies
OmniActive seeks to improve lives by enhancing nutrition and wellness through science and innovation
The accelerated growth of Medix Biochemica will establish its status as the ultimate IVD raw materials supplier
Subscribe To Our Newsletter & Stay Updated
